Constitutive Nuclear Factor-kappa B Activity Is Required for Central Neuron Survival

The function of nuclear factor (NF)-kappaB within the developing and mature CNS is controversial. We have generated transgenic mice to reveal NF-kappaB transcriptional activity in vivo. As expected, constitutive NF-kappaB activity was observed within immune organs, and tumor necrosis factor-inducibl...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 22; no. 19; pp. 8466 - 8475
Main Authors Bhakar, Asha L, Tannis, Laura-Lee, Zeindler, Christine, Russo, Maria Pia, Jobin, Christian, Park, David S, MacPherson, Sandra, Barker, Philip A
Format Journal Article
LanguageEnglish
Published United States Soc Neuroscience 01.10.2002
Society for Neuroscience
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The function of nuclear factor (NF)-kappaB within the developing and mature CNS is controversial. We have generated transgenic mice to reveal NF-kappaB transcriptional activity in vivo. As expected, constitutive NF-kappaB activity was observed within immune organs, and tumor necrosis factor-inducible NF-kappaB activity was present in mesenchymal cells. Intriguingly, NF-kappaB activity was also prominent in the CNS throughout development, especially within neocortex, olfactory bulbs, amygdala, and hippocampus. NF-kappaB in the CNS was restricted to neurons and blocked by overexpression of dominant-negative NF-kappaB-inducible kinase or the IkappaBalphaM super repressor. Blocking endogenous neuronal NF-kappaB activity in cortical neurons using recombinant adenovirus induced neuronal death, whereas induction of NF-kappaB activity increased levels of anti-apoptotic proteins and was strongly neuroprotective. Together, these data demonstrate a physiological role for NF-kappaB in maintaining survival of central neurons.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0270-6474
1529-2401
DOI:10.1523/jneurosci.22-19-08466.2002